Patients infected with either severe acute respiratory syndrome coronavirus (SARS-CoV) or SARS-CoV-2 produce antibodies that bind to the other coronavirus, but the cross-reactive antibodies are not cross protective, at least ...
May 18, 2020
0
289
Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected by a health care worker, according to a small study by researchers at ...
Jun 12, 2020
0
271
A team of researchers affiliated with several institutions in China has found evidence of hotspots for airborne SARS-CoV-2 RNA at several sites in China. In their paper published in the journal Nature, the group describes ...
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers ...
Nov 18, 2022
0
951
Could we have some immunity to SARS-CoV-2, the virus that causes COVID-19, without ever having been exposed to it?
Aug 20, 2020
0
12
Oxford University researchers have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell 'memory' to potentially fight future infections.
Sep 7, 2020
0
320
The search for an AIDS cure has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be ...
Dec 18, 2019
0
44
Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...
Feb 14, 2023
0
138
One of the pressing questions about COVID-19 remains: How long does immunity last? One key indicator of immunity is the presence of virus-specific antibodies. Previous studies have provided conflicting accounts about whether ...
Nov 3, 2020
1
80
Virologists thought they had seen the worst of SARS-CoV-2's variants when delta emerged in the spring of 2021, but by fall a new one was in circulation with a slew of spike protein mutations that took the scientific community ...
